SOLARIS PHARMA CORP FDA Approval ANDA 213648

ANDA 213648

SOLARIS PHARMA CORP

FDA Drug Application

Application #213648

Application Sponsors

ANDA 213648SOLARIS PHARMA CORP

Marketing Status

Prescription001

Application Products

001GEL;VAGINAL0.75%0METRONIDAZOLEMETRONIDAZOLE

FDA Submissions

UNKNOWN; ORIG1AP2021-10-14STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB

CDER Filings

SOLARIS PHARMA CORP
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213648
            [companyName] => SOLARIS PHARMA CORP
            [docInserts] => ["",""]
            [products] => [{"drugName":"METRONIDAZOLE","activeIngredients":"METRONIDAZOLE","strength":"0.75%","dosageForm":"GEL;VAGINAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/14\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-10-14
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.